|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02877 SHINEWAY PHARM
Nominal 
8.410 +0.080 (+0.960%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 932,635 | 1,109,676 | 703,150 | 638,566 |
| Net Cash from / (used in) Investing Activities | -- | (49,540) | (45,420) | 395,011 | (305,591) |
| Net Cash from / (used in) Financing Activities | -- | (26,738) | (250,038) | (828,935) | (329,788) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 856,357 | 814,218 | 269,226 | 3,187 |
| Cash & Cash Equivalents at beginning of period | -- | 5,026,265 | 4,205,722 | 3,943,010 | 3,946,006 |
| Effect of Foreign Exchange Rate Changes | -- | 6,154 | 6,325 | (6,514) | (6,183) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 5,888,776 | 5,026,265 | 4,205,722 | 3,943,010 |
| Remarks: | Real time quote last updated: 15/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 626,479 |
| %Change | 27.472% |
| EPS / (LPS) | RMB 0.830 |
| NBV Per Share (¥) | RMB 8.871 |